APA (7th ed.) Citation

Rossi, S., Motta, C., Studer, V., De Chiara, V., Barbieri, F., Monteleone, F., . . . Centonze, D. (2013). Effect of glatiramer acetate on disease reactivation in MS patients discontinuing natalizumab. European Journal of Neurology, 20(1), 87. https://doi.org/10.1111/j.1468-1331.2012.03794.x

Chicago Style (17th ed.) Citation

Rossi, S., et al. "Effect of Glatiramer Acetate on Disease Reactivation in MS Patients Discontinuing Natalizumab." European Journal of Neurology 20, no. 1 (2013): 87. https://doi.org/10.1111/j.1468-1331.2012.03794.x.

MLA (9th ed.) Citation

Rossi, S., et al. "Effect of Glatiramer Acetate on Disease Reactivation in MS Patients Discontinuing Natalizumab." European Journal of Neurology, vol. 20, no. 1, 2013, p. 87, https://doi.org/10.1111/j.1468-1331.2012.03794.x.